ACH

SEC Filing Summary: Owens & Minor, Inc. (10-Q)

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Owens & Minor, Inc., a distributor of medical and surgical supplies. The report covers the quarterly period ended June 30, 2002, and the six-month period ended on the same date. The filing compares these results to the corresponding periods in 2001.

Key Financial Metrics

Note: Operating cash flow for the six months ended June 30, 2002, was significantly impacted by a $70 million net decrease in receivables sold under the off-balance sheet financing facility.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 2.7% in Q2 and 3.6% for the six-month period compared to 2001. On a per-day basis, sales increased 4.4% despite having one fewer sales day in the first half of 2002.
• Profitability: Net income increased 22% in Q2 and 30% for the six-month period. Management attributes this to controlled operating expenses and reduced financing costs.
• Accounting Change: Effective January 1, 2002, the company adopted SFAS 142, eliminating goodwill amortization. This resulted in a $1.5 million increase in Q2 2001 net income (adjusted) and $3.0 million for the six-month period compared to GAAP reported figures.
• Financing Costs: Net financing costs decreased to $3.7 million in Q2 2002 from $4.7 million in Q2 2001, driven by lower outstanding financing and interest rates.
• Liquidity: Cash and cash equivalents increased significantly to $11.7 million from $0.95 million at year-end 2001. Combined outstanding debt and off-balance sheet securitization decreased by $68.2 million.

Guidance, Outlook, and Risks

• Outlook: Management expects sales growth in 2002 to be lower than in recent years due to the loss of certain customers and the completion of major customer transitions. Gross margins are expected to remain consistent with 2001 levels.
• SG&A Expenses: Excluding an anticipated $2.9 million cancellation charge for an IT contract in Q3 2002, SG&A expenses as a percentage of sales are expected to be at least 10 basis points lower than in 2001.
• Capital Expenditures: Expected to remain at approximately the same level as the first half of 2002 ($5.3 million).
• Risks: Key risks include dependence on large customers, pressure on operating margins from industry cost controls, and the potential for goodwill impairment if business volume or profitability declines. The company also faces interest rate risk on its variable-rate financing and swaps.
• Unusual Items: A $2.9 million liability for IT contract cancellation costs is expected to be recorded in Q3 2002. Restructuring credits of $0.2 million (Q2) and $0.2 million (6 months) were recorded due to lower-than-anticipated costs from a 1998 downsizing plan.

Investor Verification Checklist

• Goodwill Amortization Impact: Verify the adjusted net income figures excluding goodwill amortization to understand core operational performance trends.
• Receivables Financing: Confirm the status of the $225 million off-balance sheet receivables facility and the impact of the $70 million reduction in receivables sold on operating cash flow.
• Upcoming Charges: Monitor the Q3 2002 financials for the anticipated $2.9 million IT contract cancellation charge.
• Customer Concentration: Assess the risk associated with the loss of specific customers mentioned in the sales discussion and the company's ability to replace that volume.
• Debt Covenants: Review the new credit facility terms (effective April 30, 2002) regarding leverage ratios and fixed charge coverage requirements.